Merck Announces Results from Investigational IMPROVE-IT Study of VYTORIN Published in NEJoM
June 03, 2015 at 17:00 PM EDT
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the New England Journal of Medicine published ...